Drug Patent Watch

JANUARY 9, 2025

The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation. In 2017, small and medium-sized biotech companies accounted for 51% of FDA market approvals, while large pharma companies were the originators in only 28% of approvals[4].

Compliance 52

Compliance Drug Development Pharma Companies Therapies 52

The Connected Lab

APRIL 8, 2020

If we think about research in more traditional areas such as oncology, gastroenterology, and CNS disorders where large amounts of data have already been produced, AI, ML, and DL can help discover new compounds that could become new drugs, uncover or repurpose drugs, and improve the area of personalized medicine.

Pharma Companies 52

Pharma Companies Laboratories Drugs FDA Approval 52

Drug Target Review

JANUARY 19, 2024

Could you share an example of a specific project or research that you have worked on and the impact it has had in your field? I worked on a project that required development of a highly sensitive method and analysis of an active pharmaceutical ingredient to determine accurate levels of two potential genotoxic impurities.

Synthetic Chemistry 106

Synthetic Chemistry Analytical Chemistry Pharmaceuticals Pharma Companies 106

PPD

JULY 13, 2023

At the beginning of 2023, the PPD clinical research business of Thermo Fisher Scientific surveyed 120 drug developers across the pharmaceutical, biopharmaceutical and biotechnology sectors (referred to collectively as “pharma”) to learn more about sponsors’ current needs for site and patient recruitment services.

Pharma Companies 52

Pharma Companies Clinical Trials Trials Clinical Research 52

The Pharma Data

OCTOBER 30, 2020

Khinast. GRAZ, AUSTRIA, October 30, 2020 /24-7PressRelease/ — The Research Center Pharmaceutical Engineering GmbH (RCPE), a global leader in pharmaceutical engineering sciences, has been awarded FDA funding for two projects commencing in the 4th quarter of 2020. ” Prof.

FDA 52

FDA Engineering Pharma Companies Pharmaceuticals 52

Drug Target Review

MAY 23, 2023

Algae – an overlooked resource for new therapies It is only in recent years that algae research has expanded beyond their potential for producing biodiesel, to also consider them as a bio-resource, not only for novel prebiotics but also for compounds with unique structures and pharmaceutically relevant bioactivities.

Drugs 75

Drugs Small Molecule Production Disease 75

Drug Target Review

OCTOBER 1, 2024

Following clinical practice, I transitioned to the world of pharmaceutical companies which also had its challenges as I had to learn everything from scratch and use my experience and knowledge differently. Could you share an example of a specific project or research that you have worked on and the impact it has had in your field?

Doctors 97

Doctors Therapies Science Pharma Companies 97

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

H1 Blog

JULY 30, 2024

The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research. This effort seeks to provide the pharmaceutical industry with more accurate representation of patient populations, thereby enhancing the safety and efficacy for prescription drugs and medical devices.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

Eye on FDA

JANUARY 9, 2022

As noted in the past, there are two primary means for understanding the agency’s latest thinking with respect to promotional communications from pharmaceutical companies – the content and pattern of enforcement and the issuance of guidance documents to shed light on the parameters that exist. Why This is a Fail.

FDA 64

FDA Pharma Companies Pharmaceutical Companies Treatment 64

The Pharma Data

DECEMBER 11, 2020

The University of Oxford has regularly appeared in our updates since July 2020, as its team of researchers leads an ongoing clinical trial for the Covid-19 vaccine. More recently, the university has released news of its collaboration with Thermo Fisher Scientific as it looks to discover an immune Covid-19 response pre- and post-vaccination.

Vaccine 52

Vaccine Immune Response Pharma Companies Virus 52

The Pharma Data

JANUARY 4, 2021

Rothenberg did not provide any information as to what his next role may be – whether he will take over the helm of a pharma company or assume a role on one or more boards of directors. Rothenberg took over as Pfizer CMO in January 2019, but spent more than 12 years in total working for the pharmaceutical giant.

Pharma Companies 52

Pharma Companies Clinical Development Clinical Research International 52

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. What is a value-added medicine?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

JANUARY 17, 2021

Billions of dollars are poured into research each year, yet the push for effective treatment and hope for a cure is dashed time and again. Connecticut-based Biohaven Pharmaceuticals was looking pretty hopeful with its third-generation prodrug to modulate glutamate, the most abundant excitatory neurotransmitter in the human body.

Pharma Companies 52

Pharma Companies Disease Treatment Trials 52

Alta Sciences

MARCH 27, 2024

As if that isn’t enough, she is also working toward her PhD, with research focusing on the impact of supramental awareness on disease prevention, healing, and health. I started researching natural treatments and discovered an exceptional data set in the public domain that guided many of my own treatment choices over the years.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

The Pharma Data

SEPTEMBER 14, 2020

The availability of new analytics tools and the expansion of data sources has led many pharma companies to adopt a data-driven approach to decision-making during the early stages of the clinical trial planning process. Accelerating your clinical trial supply through digitalization.

Clinical Supply 52

Clinical Supply Clinical Trials Pharma Companies Trials 52

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … Deep Learning Deep learning, a subset of ML, employs neural networks with multiple layers to model complex patterns in data.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

LifeSciVC

NOVEMBER 28, 2023

We had a significantly limited set of Phase 1B data in psoriasis patients for TYK2 at the time, and we were now free to speak to pharma companies interested in our TYK2 program. Equity research analysts surveyed that 90% of physicians and investors believed that BMS would get a Black Box Warning by FDA like other JAK family drugs.

Marketing 101

Marketing FDA Pharma Companies Government 101

The Open Targets Blog

OCTOBER 24, 2023

Amir has worked in the pharma/biotech sector for over ten years, using bioinformatics for data integration and multi-omics analysis for target identification and validation, and his team were an early adopter of Open Targets Genetics.  We released the package on my personal GitHub so that I could keep updating it in the future.

Bioinformatics 61

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 61

H1 Blog

NOVEMBER 15, 2023

Since KOLs play such a critical role, engaging with the right KOLs is a key strategy for pharmaceutical companies to stay ahead of the game. Compliance ensures that interactions between pharmaceutical companies and KOLs are transparent, fair, and free from any undue influence.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

The Pharma Data

NOVEMBER 27, 2020

This week, another pharma company revealed a new technology device that can detect if a patient is infectious or not, while the Russian government published results of its Sputnik V vaccine, claiming it is more than 95 per cent efficient 42 days after the first dose.

Virus 52

Virus Vaccine International Immune Response 52

The Pharma Data

JANUARY 31, 2021

It advises the Federal Government and the governments of the German states on questions concerning the content and structural development of science, research and higher education to help secure the international competitiveness. He subsequently was accepted at Harvard Medical School in Boston, USA, where he received his Ph.D.

Science 52

Science Government Medical Schools Pharma Companies 52

The Pharma Data

DECEMBER 17, 2020

Hartfield previously served as CEO of Vitae Pharmaceuticals prior to its acquisition by Allergan. X4 Pharmaceuticals – Diego Cadavid was named chief medical officer of Boston-based X4 Pharmaceuticals. Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs.

Small Molecule 52

Small Molecule Clinical Development Engineering Pharmaceuticals 52

The Pharma Data

NOVEMBER 11, 2020

TOKYO & AUSTIN, Texas–( BUSINESS WIRE )– Taiho Pharmaceutical Co., We are honored to partner with Taiho, a Japanese pharmaceutical company with a commitment to the respiratory field, for the development and commercialization of LTI-01 in Japan. About Taiho Pharmaceutical Co., 12, 2020 11:00 UTC.

Licensing 40

Licensing Licensing Treatment Pharma Companies 40

Drug Target Review

JULY 11, 2024

Scientists and, increasingly, biotechs and pharma companies hope to create a more detailed map of the surfaceome, the entire cancer cell surface and its membrane-bound proteins. Surfaceome research has been described in academic papers for more than a decade but is becoming more important as the search for new targets intensifies.

Therapies 56

Therapies RNA Pharma Companies Disease 56

H1 Blog

MARCH 27, 2023

As the primary interface between healthcare providers (HCPs) and pharmaceutical companies, medical science liaisons (MSLs) have a unique opportunity to engage with HCPs in clinical discussions and bridge care gaps by providing crucial insights into evidence-based medicine.

Science 52

Science Pharma Companies Pharmaceutical Companies Treatment 52

Elrig

APRIL 29, 2024

Miguel Gancedo Rodrigo Miguel Gancedo Rodrigo Research Investigator, Isomorphic Labs My name is Miguel, and I’m from Murcia, Spain. Rising from Research Scientist to Senior Scientist, I supported early-stage DD efforts within their Protein Science group, based in Cambridge, UK.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

The Pharma Data

DECEMBER 21, 2020

Medical Director and Head of the Immunological Tumor Group at University Medicine Halle, Germany, who is a renowned oncology clinician and researcher specializing in the analysis of immuno-oncology treatments and their interaction with tumor tissues. Mascha Binder, M.D.,

Vaccine 52

Vaccine Trials Clinical Trials Clinical Development 52

Advarra

JULY 19, 2022

The sponsor is the pharmaceutical company conducting the trial. If you mean using a different contract research organization (CRO) for the different phases of clinical trials – that’s different. A: Working in a pharmaceutical company is the best way to learn this. A: This does not usually happen.

Packaging 52

Packaging FDA Trials Regulations 52

Vial

FEBRUARY 19, 2024

Explore the groundbreaking VersAptx bioconjugation platform, designed to elevate cancer therapies and uncover the delicate balance between clinical excellence and commercial viability in the dynamic landscape of pharmaceuticals. I veered into oncology and oncology research earlier in my career. Ahmed Hamby: Thank you.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

BioPharma Drive: Drug Pricing

JULY 8, 2025

Since Arvinas’ findings, another company, Kymera Therapeutics, showed that a protein-destroying medicine it developed may be able to stifle a drug target others have struggled to reach. For years, researchers struggled to develop an effective method for directing the E3 ligase. There’s a real burning desire to show more progress.”

Targeted Protein Degradation 124

Targeted Protein Degradation Small Molecule Disease Therapies 124

Drug Target Review

MAY 26, 2025

Daniel Galbraith, Chief Scientific Officer at Solvias , brings extensive expertise in the pharmaceutical and biotechnology sectors. In his role, he provides both strategic and technical guidance to Solvias, a global Contract Research Organisation (CRO) that offers critical analytical services to the pharmaceutical industry.

Drug Development 52

Drug Development Drugs Therapies Pharmaceuticals 52

The Pharma Data

OCTOBER 14, 2020

AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. AOP anticipates new opportunities in Austria as a hub for research and business. All jobs have been maintained and the workforce has grown from about 220 to 350.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Pharmaceutical Companies 52

Codon

FEBRUARY 13, 2024

Tom Ireland writes about the companies and technologies that are reimagining phage therapy. Goodsell, RCSB Protein Data Bank and Scripps Research. 1 Yet even after more than two decades of research, media hype, and dozens of clinical trials and biotech start-ups that have come and gone, phage therapy has not scaled.

Therapies 137

Therapies Virus DNA Clinical Trials 137

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.

Pharma Companies 112

Pharma Companies Licensing Licensing Disease 112

The Pharma Data

NOVEMBER 16, 2020

When taken on its own, the polypill reduced by about 20% the risk of heart attack, stroke, procedures to reopen clogged arteries and other heart disease, the researchers reported. The polypill/aspirin combination reduced heart problems and deaths by 31%, the researchers discovered. About 4.1% of those with the placebo.

Health Insurance Companies 52

Health Insurance Companies Doctors Medical Schools Pharma Companies 52

The Pharma Data

DECEMBER 23, 2020

is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus. See: PLOS ONE ). AIM CEO Thomas K. If successful, this may change millions of lives for the better.”.

Clinical Trials 52

Clinical Trials Trials Virus Therapies 52